Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Dürig, Jan"'
Autor:
Denker S; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Berlin, Germany., Bittner A; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Berlin, Germany., Frick M; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Kase J; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Hoffmann J; Department of Hematology, Oncology, Immunology, Philipps-University Marburg, University Hospital Giessen and Marburg, Marburg, Germany., Trenker C; Department of Hematology, Oncology, Immunology, Philipps-University Marburg, University Hospital Giessen and Marburg, Marburg, Germany., Keller U; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Bogner C; Medical Clinic and Policlinic II, Klinikum rechts der Isar, Technical University Munich, München, Germany., Hüttmann A; Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany., Dürig J; Klinik für Hämatologie, Universitätsklinikum Essen, Universität Duisburg-Essen, Essen, Germany., Janz M; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Mathas S; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany., Marks R; Faculty of Medicine and Medical Center, Department of Hematology/Oncology/Stem Cell Transplantation, University of Freiburg, Freiburg, Germany., Krohn U; Faculty of Medicine and Medical Center, Department of Hematology/Oncology/Stem Cell Transplantation, University of Freiburg, Freiburg, Germany., Na IK; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Charité - Universitätsmedizin Berlin, Berlin Institute of Health, Berlin, Germany.; German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Experimental and Clinical Research Center (ECRC), Max Delbrück Center for Molecular Medicine and Charité-Universitätsmedizin Berlin, Berlin, Germany., Bullinger L; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Schmitt CA; Charité - Universitätsmedizin Berlin, Medical Department, Division of Hematology, Oncology and Tumor Immunology, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2022 Jan; Vol. 63 (1), pp. 84-92. Date of Electronic Publication: 2021 Aug 20.
Autor:
Pflug N; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Cramer P; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Robrecht S; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Bahlo J; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Westermann A; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Fink AM; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Schrader A; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Mayer P; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Oberbeck S; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Seiler T; b Medizinische Klinik und Poliklinik III , LMU University of Munich , Munich , Germany., Zenz T; c National Center for Tumor Diseases Heidelberg , Heidelberg , Germany., Dürig J; d Klinik für Hämatologie , University of Essen , Essen , Germany., Kreuzer KA; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Stilgenbauer S; e Department of Internal Medicine III , University of Ulm , Ulm , Germany., Eichhorst B; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Hallek M; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Herling M; a Department I of Internal Medicine, Center for Integrated Oncology Köln Bonn, Deutsche CLL Studiengruppe (DCLLSG), Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD), and Center of Molecular Medicine Cologne (CMMC) , University of Cologne , Cologne , Germany., Hopfinger G; f AKH Wien , Universitätsklinik für Innere Medizin I , Vienna , Austria.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Mar; Vol. 60 (3), pp. 649-657. Date of Electronic Publication: 2018 Sep 20.
Autor:
Awwad MHS; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Kriegsmann K; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Plaumann J; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Benn M; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Hillengass J; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Raab MS; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Bertsch U; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; National Center for Tumour Diseases, University of Heidelberg, Heidelberg, Germany., Munder M; Department of Hematology, Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Weisel K; Department of Hematology, Oncology, Immunology and Rheumatology, University of Tübingen, Tübingen, Germany., Salwender HJ; Asklepios Klinik Hamburg Altona, Germany., Hänel M; Klinikum Chemnitz, Germany., Fenk R; Department of Hematology, Oncology and Clinical Immunology, University Düsseldorf, Düsseldorf, Germany., Dürig J; Department of Hematology, University of Essen, Essen, Germany., Müller-Tidow C; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Goldschmidt H; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.; National Center for Tumour Diseases, University of Heidelberg, Heidelberg, Germany., Hundemer M; Department of Hematology, Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2018 Aug 01; Vol. 7 (10), pp. e1486356. Date of Electronic Publication: 2018 Aug 01 (Print Publication: 2018).
Autor:
Jewell RC; a Novartis Pharmaceuticals , Morrisville , NC , USA., Kipps TJ; b UCSD Moores Cancer Center , La Jolla , CA , USA., Dürig J; c Klinik für Hämatologie , Universitätsklinikum Essen , Essen , Germany., Griskevicius L; d Vilnius University Hospital Santariskiu Klinikos, Vilnius University , Vilnius , Lithuania., Stilgenbauer S; e Department of Internal Medicine III , Universitätsklinikum Ulm , Ulm , Germany., Smolej L; f 4th Department of Internal Medicine - Hematology , University Hospital and Faculty of Medicine , Hradec Králové , Czech Republic., Mayer J; g Department of Internal Medicine/Hemato-Oncology , University Hospital Brno , Brno , Czech Republic., Hess G; h Johannes Gutenberg University , Mainz , Germany., Hernandez-Ilizaliturri FJ; i Roswell Park Cancer Institute , Buffalo , NY , USA., Padmanabhan-Iyer S; j Cancer Therapy and Research Center , San Antonio , TX , USA., Fang L; k Pharstat Inc. , Raleigh , NC , USA., Goldstein N; a Novartis Pharmaceuticals , Morrisville , NC , USA., Gorczyca M; l GlaxoSmithKline , Collegeville , PA , USA., Gupta I; m Novartis Pharmaceuticals , King of Prussia , PA , USA., Lisby S; n Genmab , Copenhagen , Denmark., Wierda WG; o MD Anderson Cancer Center, The University of Texas , Houston , TX , USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2017 Feb; Vol. 58 (2), pp. 348-356. Date of Electronic Publication: 2016 Jul 07.
Autor:
Stiefelhagen M; a Department of Medicine I, Laboratory of Lymphocyte Signaling and Oncoproteome, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD) , University of Cologne , Germany ;, Gigel C; a Department of Medicine I, Laboratory of Lymphocyte Signaling and Oncoproteome, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD) , University of Cologne , Germany ;, Vasyutina E; a Department of Medicine I, Laboratory of Lymphocyte Signaling and Oncoproteome, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD) , University of Cologne , Germany ;, Möllmann M; b Clinic of Hematology, University Hospital of Essen , Germany., Breuer A; a Department of Medicine I, Laboratory of Lymphocyte Signaling and Oncoproteome, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD) , University of Cologne , Germany ;, Mayer P; a Department of Medicine I, Laboratory of Lymphocyte Signaling and Oncoproteome, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD) , University of Cologne , Germany ;, Dürig J; b Clinic of Hematology, University Hospital of Essen , Germany., Herling M; a Department of Medicine I, Laboratory of Lymphocyte Signaling and Oncoproteome, Excellence Cluster for Cellular Stress Response and Aging-Associated Diseases (CECAD) , University of Cologne , Germany ;
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2016 Sep; Vol. 57 (9), pp. 2235-8. Date of Electronic Publication: 2016 Jan 12.
Autor:
Sellmann L; a Department of Haematology , Medical Faculty, University of Duisburg-Essen , Essen , Germany .; b Institute of Cell Biology (Cancer Research), Medical Faculty , University of Duisburg-Essen , Essen , Germany ., Scholtysik R; b Institute of Cell Biology (Cancer Research), Medical Faculty , University of Duisburg-Essen , Essen , Germany ., de Beer D; c Experimental Haematology, Department of Clinical Research , University Bern , Switzerland , and., Eisele L; a Department of Haematology , Medical Faculty, University of Duisburg-Essen , Essen , Germany ., Klein-Hitpass L; b Institute of Cell Biology (Cancer Research), Medical Faculty , University of Duisburg-Essen , Essen , Germany ., Nückel H; a Department of Haematology , Medical Faculty, University of Duisburg-Essen , Essen , Germany ., Dührsen U; a Department of Haematology , Medical Faculty, University of Duisburg-Essen , Essen , Germany ., Dürig J; a Department of Haematology , Medical Faculty, University of Duisburg-Essen , Essen , Germany ., Röth A; a Department of Haematology , Medical Faculty, University of Duisburg-Essen , Essen , Germany ., Baerlocher GM; c Experimental Haematology, Department of Clinical Research , University Bern , Switzerland , and.; d Department of Haematology , University Hospital , Bern , Switzerland.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2016; Vol. 57 (3), pp. 590-5. Date of Electronic Publication: 2015 Oct 12.
Autor:
Goede V; a German CLL Study Group, Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne , Cologne , Germany .; b Department of Geriatric Medicine , St Marien Hospital , Cologne , Germany ., Bahlo J; a German CLL Study Group, Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne , Cologne , Germany ., Chataline V; a German CLL Study Group, Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne , Cologne , Germany ., Eichhorst B; a German CLL Study Group, Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne , Cologne , Germany ., Dürig J; c Department of Hematology , University Hospital Essen , Essen , Germany ., Stilgenbauer S; d Department III of Internal Medicine , University Hospital Ulm , Ulm , Germany ., Kolb G; e Department of Geriatric Medicine , Bonifatius Hospital , Lingen , Germany ., Honecker F; f Department of Oncology , Hematology, Bone Marrow Transplantation with section Pneumology, University Hospital Hamburg-Eppendorf , Hamburg , Germany .; g Tumor and Breast Center ZeTuP , St. Gallen , Switzerland ., Wedding U; h Department II of Internal Medicine , University Hospital Jena , Jena , Germany , and., Hallek M; a German CLL Study Group, Department I of Internal Medicine , Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne , Cologne , Germany .; i Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (CECAD), University of Cologne , Cologne , Germany.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2016; Vol. 57 (4), pp. 789-96. Date of Electronic Publication: 2015 Oct 13.
Autor:
Wendtner CM; a Klinikum Schwabing, Academic Teaching Hospital of University of Munich , Munich , Germany ;; b Department I of Internal Medicine , University of Cologne , Cologne , Germany ;, Hallek M; b Department I of Internal Medicine , University of Cologne , Cologne , Germany ;; c Cologne Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases (CECAD) , Cologne , Germany ;, Fraser GA; d Juravinski Cancer Centre, McMaster University , Hamilton , Ontario , Canada ;, Michallet AS; e Hospices Civils De Lyon, Centre Hospitalier Lyon Sud , Pierre Bénite , Lyon , France ;, Hillmen P; f St James's Institute of Oncology , Leeds , UK ;, Dürig J; g University Hospital Essen , Essen , Germany ;, Kalaycio M; h Cleveland Clinic , Cleveland , OH , USA ;, Gribben JG; i Barts Cancer Institute, Queen Mary, University of London , London , UK ;, Stilgenbauer S; j Department of Internal Medicine III , Ulm University , Ulm , Germany ;, Buhler A; j Department of Internal Medicine III , Ulm University , Ulm , Germany ;, Kipps TJ; k University of California San Diego Moores Cancer Center , La Jolla , CA , USA ;, Purse B; l Celgene Corporation , Summit , NJ , USA ;, Zhang J; l Celgene Corporation , Summit , NJ , USA ;, De Bedout S; m Celgene Corporation , Boudry , Switzerland ;, Mei J; l Celgene Corporation , Summit , NJ , USA ;, Chanan-Khan A; n Mayo Clinic , Jacksonville , FL , USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2016; Vol. 57 (6), pp. 1291-9. Date of Electronic Publication: 2016 Jan 14.
Autor:
Sellmann L; Department of Hematology, Medical Faculty, University of Duisburg-Essen, Essen, Germany. ludger.sellmann@uk-essen.de, Carpinteiro A, Nückel H, Scholtysik R, Siemer D, Klein-Hipass L, Kube D, Dürig J, Dührsen U, Stanelle J, Küppers R
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2012 Jul; Vol. 53 (7), pp. 1282-8. Date of Electronic Publication: 2012 Feb 13.